Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Imugene ( (AU:IMU) ).
Imugene Limited has called an Extraordinary General Meeting to be held on 23 April 2026 at 9:00 a.m. Sydney time, offering both a physical venue in Sydney and a virtual option via the Automic online platform. The company is encouraging shareholders to register early with Automic so they can watch, listen, vote, and ask questions online, underscoring its continued shift toward hybrid meeting formats and broader digital participation in corporate governance.
The meeting logistics emphasize streamlined online access, requiring shareholders to set up an Automic account using their holder numbers and then follow a guided process on the day to register, join, and vote. This approach is designed to reduce day-of delays, facilitate engagement from remote investors, and potentially increase overall shareholder participation in key corporate decisions.
The most recent analyst rating on (AU:IMU) stock is a Hold with a A$0.14 price target. To see the full list of analyst forecasts on Imugene stock, see the AU:IMU Stock Forecast page.
More about Imugene
Imugene Limited is a biotechnology company focused on developing immuno-oncology therapies aimed at treating and improving outcomes for cancer patients. The company is listed in Australia and has a broad base of shareholders who participate in governance through general meetings and online voting platforms.
YTD Price Performance: -58.90%
Average Trading Volume: 1,715,264
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$53.55M
For an in-depth examination of IMU stock, go to TipRanks’ Overview page.